Deal Library / Pharma BD Deal Intelligence

UCB S.A. — Pharma Deals

The Pharma Closeout tracks 5 deals, $8.5B in disclosed deal value for UCB S.A..

Median Critic Score: 86

All 5 deals

• UCB S.A. / Candid Therapeutics, Inc. — 2026 · $2.2B
• UCB S.A. / Neurona Therapeutics, Inc. — 2026 · $1.1B
• UCB S.A. / Antengene Corporation Limited — 2026 · $1.2B
• UCB S.A. / Zogenix Inc. — 2022 · $1.9B
• UCB S.A. / Ra Pharmaceuticals, Inc. — 2019 · $2.1B

← Deal Library  ·  Interactive search  ·  How we score deals